Iterative Scopes, a Gastroenterology AI company with a focus on applying computer vision analytics to complex endoscopy problems, today announced the closure of a $5.2 million seed round – bringing the total amount raised to over $7 million dollars. The financing was led by Wavemaker Partners and joined by Tau Ventures, p5hv, Okta co-founder Freddie Kerrest, and a number of family office funds.
The investment will enable progress through clinical trials and commercialization of its proprietary computer vision technology in 2020.
“We invested in Iterative Scopes because they impressed us with identifying a strong need, building an execution-focused team, and creating a differentiated product,” said Amit Garg, Managing Partner of Tau Ventures.
“We are excited to move forward into our next phase of development with an all-star team and investors. We are on track to deliver a number of products into the Gastrointestinal endoscopic suite, working alongside physicians to improve patient outcomes,” said Jonathan Ng, CEO of Iterative Scopes.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: BioSpace
